Market cap
$950.861 M
$1.48 -5.73%
Close of 7 Aug 2026
Revenue
—
Not reported
Earnings
-$83.5M
Loss-making
Shares outstanding
642,473,409
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations — ranked by market cap
All 501 →Where these numbers come from
Share counts and financials for Geron are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.